Male subclinical hypogonadism and late-onset hypergonadotrophic hypogonadism: mechanisms, endothelial function, and interplay between reproductive hormones, undercarboxylated osteocalcin, and endothelial dysfunction

References

• Tajar A, Forti G, O'Neill TW, the EMAS Group, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing study. J Clin Endocrinol Metab. 2010;95(4):1810–1818.
   PubMed Web of Science ®Google Scholar
• Corradi PF, Corradi RB, Greene LW. Physiology of the hypothalamic pituitary gonadal axis in the male. Urol Clin North Am. 2016;25(1):151–162.
   Google Scholar
• Hiort O, Holterhus PM, Horter T, et al. Significance of mutations in the androgen receptor gene in males with idiopathic infertility. J Clin Endocrinol Metab. 2000;85(8):2810–2815.
   PubMed Web of Science ®Google Scholar
• de Ronde W, van der Schouw YT, Muller M, et al. Associations of sex-hormone-binding globulin (SHBG) with non-SHBG-bound levels of testosterone and estradiol in independently living men. J Clin Endocrinol Metab. 2005;90(1):157–162.
   PubMed Web of Science ®Google Scholar
• Giannetta E, Gianfrilli D, Barbagallo F, et al. Subclinical male hypogonadism. Best Pract Res Clin Endocrinol Metab. 2012;26(4):539–550.
   PubMed Web of Science ®Google Scholar
• Tajar A, O'Connell MD, Mitnitski AB, European Male Aging Study Group, et al. Frailty in relation to variations in hormone levels of the hypothalamic-pituitary-testicular axis in older men: results from the European male aging study. J Am Geriatr Soc. 2011;59(5):814–821.
   PubMed Web of Science ®Google Scholar
• Corona G, Maseroli E, Rastrelli G, et al. Characteristics of compensated hypogonadism in patients with sexual dysfunction. J Sex Med. 2014;11(7):1823–1834.
   PubMed Web of Science ®Google Scholar
• van den Beld AW, Huhtaniemi IT, Pettersson KSL, et al. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. J Clin Endocrinol Metab. 1999;84(4):1334–1339.
   PubMed Web of Science ®Google Scholar
• Hyde Z, Norman PE, Flicker L, et al. Elevated LH predicts ischaemic heart disease events in older men: the health in men study. Eur J Endocrinol. 2011;164(4):569–577.
   PubMed Web of Science ®Google Scholar
• Komori T. Functions of osteocalcin in bone, pancreas, testis, and muscle. IJMS. 2020;21(20):7513.
   Google Scholar
• Millar SA, Patel H, Anderson SI, et al. Osteocalcin, vascular calcification, and atherosclerosis: a systematic review and meta-analysis. Front Endocrinol. 2017;8:183.
   PubMed Web of Science ®Google Scholar
• Tacey A, Qaradakhi T, Brennan-Speranza T, et al. Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease. Nutrients. 2018;10(10):1426.
   PubMed Web of Science ®Google Scholar
• Tacey A, Millar S, Qaradakhi T, et al. Undercarboxylated osteocalcin has no adverse effect on endothelial function in rabbit aorta or human vascular cells. J Cell Physiol. 2021;236(4):2840–2849.
   PubMed Web of Science ®Google Scholar
• Eendebak RJAH, Ahern T, Swiecicka A, EMAS Group, et al. Elevated luteinizing hormone despite normal testosterone levels in older men-natural history, risk factors and clinical features. Clin Endocrinol (Oxf). 2018;88(3):479–490.
   PubMed Web of Science ®Google Scholar
• Chen W, Liu ZY, Wang LH, et al. Are the aging male's symptoms (AMS) scale and the androgen deficiency in the aging male (ADAM) questionnaire suitable for the screening of late-onset hypogonadism in aging Chinese men? Aging Male. 2013;16(3):92–96.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666–3672.
   PubMed Web of Science ®Google Scholar
• Aiman J, Griffin JE, Gazak JM, et al. Androgen insensitivity as a cause of infertility in otherwise normal men. N Engl J Med. 1979;300(5):223–227.
   PubMed Web of Science ®Google Scholar
• Touboul PJ, Hennerici MG, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004–2006). an update on behalf of the advisory board of the 3rd and 4th watching the risk symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis. 2007;23(1):75–80.
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340(8828):1111–1115.
   PubMed Web of Science ®Google Scholar
• Stefanadis C, Dernellis J, Tsiamis E, et al. Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease. Eur Heart J. 2000;21(5):390–396.
   PubMed Web of Science ®Google Scholar
• Rochira V, Carani C. Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol. 2009;5(10):559–568.
   PubMed Web of Science ®Google Scholar
• Crabbe P, Bogaert V, De Bacquer D, et al. Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab. 2007;92(9):3604–3610.
   PubMed Web of Science ®Google Scholar
• Mulligan T, Iranmanesh A, Johnson ML, et al. Aging alters feed-forward and feedback linkages between LH and testosterone in healthy men. Am J Physiol. 1997;273(4):R1407–R1413.
   PubMedGoogle Scholar
• McBride JA, Carson CC, Coward RM. Testosterone deficiency in the aging male. Ther Adv Urol. 2016;8(1):47–60.
   PubMedGoogle Scholar
• Yang YY, Zheng SC, Wang WC, et al. Osteocalcin levels in male idiopathic hypogonadotropic hypogonadism: relationship with the testosterone secretion and metabolic profiles. Front Endocrinol. 2019;10:687.
   PubMed Web of Science ®Google Scholar
• Karsenty G, Oury F. Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol. 2014;382(1):521–526.
   PubMed Web of Science ®Google Scholar
• Nah K, Jung S, Kim BT. Uncarboxyolated osteocalcin inversely correlated with total testosterone level in elderly man. Korean J Fam Pract. 2017;7(5):781–785.
   Google Scholar
• Posielski N, Krieger J, Madison W, et al. Osteocalcin as a novel regulator of testosterone production: a bench to bedside study in rats and humans. J Urol. 2019;201(4S):e855 MP58–08.
   Google Scholar
• De Toni L, Guidolin D, De Filippis V, et al. Osteocalcin and sex hormone binding globulin compete on a specific binding site of GPRC6A. Endocrinology. 2016;157(11):4473–4486.
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Tanaka K, Ogawa N, et al. Undercarboxylated osteocalcin is positively associated with free testosterone in male patients with type 2 diabetes mellitus. Osteoporos Int. 2013;24(3):1115–1119.
   PubMed Web of Science ®Google Scholar
• Samavat J, Facchiano E, Cantini G, et al. Osteocalcin increase after bariatric surgery predicts androgen recovery in hypogonadal obese males. Int J Obes. 2014;38(3):357–363.
   Web of Science ®Google Scholar
• Zhong N, Xu B, Cui R, et al. Positive correlation between serum osteocalcin and testosterone in male hyperthyroidism patients with high bone turnover. Exp Clin Endocrinol Diabetes. 2016;124(07):452–456.
   PubMedGoogle Scholar
• Schwetz V, Gumpold R, Graupp M, et al. Osteocalcin is not a strong determinant of serum testosterone and sperm count in men from infertile couples. Andrology. 2013;1(4):590–594.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Alfonso H, Chubb SA, et al. Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men. J Clin Endocrinol Metab. 2015;100(1):63–71.
   PubMed Web of Science ®Google Scholar
• Morley JE, Perry HM III, Kaiser FE, et al. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc. 1993;41(2):149–152.
   PubMed Web of Science ®Google Scholar
• Ghanim H, Dhindsa S, Green K, et al. Increase in osteocalcin following testosterone therapy in men with type 2 diabetes and subnormal free testosterone. J Endocr Soc. 2019;3(8):1617–1630.
   PubMed Web of Science ®Google Scholar
• Taxel P, Kennedy DG, Fall PM, et al. The effect of aromatase inhibition on sex steroids, gonadotropins, and markers of bone turnover in older men. J Clin Endocrinol Metab. 2001;86(6):2869–2874.
   PubMed Web of Science ®Google Scholar
• Leder BZ, Finkelstein JS. Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Osteoporos Int. 2005;16(12):1487–1494.
   PubMed Web of Science ®Google Scholar
• Merlotti D, Gennari L, Stolakis K, et al. Aromatase activity and bone loss in men. J Osteoporos. 2011;2011:230671.
   PubMedGoogle Scholar
• Holmboe SA, Vradi E, Jensen TK, et al. The association of reproductive hormone levels and all-cause, cancer, and cardiovascular disease mortality in Men. J Clin Endocrinol Metab. 2015;100(12):4472–4480.
   PubMed Web of Science ®Google Scholar
• Kelly DM, Jones TH. Testosterone and cardiovascular risk in men. Front Horm Res. 2014;43:1–20.
   PubMed Web of Science ®Google Scholar
• Thirumalai A, Rubinow KB, Page ST. An update on testosterone, HDL and cardiovascular risk in men. Clin Lipidol. 2015;10(3):251–258.
   PubMed Web of Science ®Google Scholar
• Mohler ER, Ellenberg SS, Lewis CE, et al. The effect of testosterone on cardiovascular biomarkers in the testosterone trials. J Clin Endocrinol Metab. 2018;103(2):681–688. [published correction appears in J Clin Endocrinol Metab. 2020;105(1)].
   PubMed Web of Science ®Google Scholar
• Whitsel EA, Boyko EJ, Matsumoto AM, et al. Intramuscular testosterone esters and plasma lipids in hypogonadal men: a meta-analysis. Am J Med. 2001;111(4):261–269.
   PubMed Web of Science ®Google Scholar
• Cai Z, Xi H, Pan Y, et al. Effect of testosterone deficiency on cholesterol metabolism in pigs fed a high-fat and high-cholesterol diet. Lipids Health Dis. 2015;14:18–20.
   PubMed Web of Science ®Google Scholar
• Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in Middle-aged men: a meta-analysis. Clin Endocrinol. 2005;63(3):280–293.
   PubMed Web of Science ®Google Scholar
• Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82(1):29–39.
   PubMed Web of Science ®Google Scholar
• Haring R, Xanthakis V, Coviello A, et al. Clinical correlates of sex steroids and gonadotropins in men over the late adulthood: the Framingham heart study. Int J Androl. 2012;35(6):775–782.
   PubMedGoogle Scholar
• Adorni MP, Zimetti F, Cangiano B, et al. High-density lipoprotein function is reduced in patients affected by genetic or idiopathic hypogonadism. J Clin Endocrinol Metab. 2019;104(8):3097–3107.
   PubMed Web of Science ®Google Scholar
• Jones ME, Boon WC, Proietto J, et al. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab. 2006;17(2):55–64.
   PubMed Web of Science ®Google Scholar
• Papageorgiou N, Briasoulis A, Androulakis E, et al. Imaging subclinical atherosclerosis: where do we stand? Curr Cardiol Rev. 2017;13(1):47–55.
   PubMed Web of Science ®Google Scholar
• Huhtaniemi I, Mäkinen JI, Perheentupa A, et al. Late-onset hypogonadism in men. Experience from the Turku male ageing study (TuMAS). Hormones. 2008;7(1):36–45. PMID: 18359743
   PubMedGoogle Scholar
• Hsu B, Cumming RG, Naganathan V, et al. Temporal changes in androgens and estrogens are associated with all-cause and cause-specific mortality in older men. J Clin Endocrinol Metab. 2016;101(5):2201–2210.
   PubMed Web of Science ®Google Scholar
• Toth P, Li X, Rao CV, et al. Expression of functional human chorionic gonadotropin/human luteinizing hormone receptor gene in human uterine arteries. J Clin Endocrinol Metab. 1994;79(1):307–315.
   PubMed Web of Science ®Google Scholar
• Berndt S, Perrier d'Hauterive S, Blacher S, et al. Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. Faseb J. 2006;20(14):2630–2263.
   PubMed Web of Science ®Google Scholar
• Lu M, Yang CB, Gao L, et al. Mechanism of subclinical hypothyroidism accelerating endothelial dysfunction (review). Exp Ther Med. 2015;9(1):3–10.
   PubMed Web of Science ®Google Scholar
• Empen K, Lorbeer R, Dörr M, et al. Association of testosterone levels with endothelial function in men: results from a population-based study. Arterioscler Thromb Vasc Biol. 2012;32(2):481–486.
   PubMed Web of Science ®Google Scholar
• Stanhewicz AE, Wenner MM, Stachenfeld NS. Sex differences in endothelial function important to vascular health and overall cardiovascular disease risk across the lifespan. Am J Physiol Heart Circ Physiol. 2018;315(6):H1569–H1588.
   PubMed Web of Science ®Google Scholar
• Fukui M, Kitagawa Y, Kamiuchi K, et al. Association between serum estradiol concentrations and carotid atherosclerosis in men with type 2 diabetes mellitus. Metabolism. 2008;57(2):285–289.
   PubMed Web of Science ®Google Scholar
• Brand JS, den Ouden ME, Schuurmans MJ, et al. Endogenous sex hormones and subclinical atherosclerosis in middle-aged and older men. Int J Cardiol. 2013;168(1):574–576.
   PubMed Web of Science ®Google Scholar
• Chan YX, Knuiman MW, Hung J, et al. Testosterone, dihydrotestosterone and estradiol are differentially associated with carotid intima-media thickness and the presence of carotid plaque in men with and without coronary artery disease. Endocr J. 2015;62(9):777–786.
   PubMed Web of Science ®Google Scholar
• Stelmaszewska J, Chrusciel M, Doroszko M, et al. Revisiting the expression and function of follicle-stimulation hormone receptor in human umbilical vein endothelial cells. Sci Rep. 2016;6:37095.
   PubMed Web of Science ®Google Scholar
• Melloni C, Roe MT. Androgen deprivation therapy and cardiovascular disease. Urol Oncol. 2020;38(2):45–52.
   PubMed Web of Science ®Google Scholar
• Wallace IR, McKinley MC, Bell PM, et al. Sex hormone binding globulin and insulin resistance. Clin Endocrinol. 2013;78(3):321–329.
   PubMed Web of Science ®Google Scholar
• Yeap BB, Marriott RJ, Antonio L, et al. Serum testosterone is inversely and sex hormone-binding globulin is directly associated with all-cause mortality in men. JCEM. 2021;106(2):e625–e637.
   PubMed Web of Science ®Google Scholar
• Gyawali P, Martin SA, Heilbronn LK, et al. Cross-sectional and longitudinal determinants of serum sex hormone binding globulin (SHBG) in a cohort of community-dwelling men. PLoS One. 2018;13(7):e0200078.
   PubMed Web of Science ®Google Scholar
• Mathews L, Subramanya V, Zhao D, et al. Endogenous sex hormones and endothelial function in postmenopausal women and men: the multi-ethnic study of atherosclerosis. J Womens Health. 2019;28(7):900–909.
   Web of Science ®Google Scholar
• Prats-Puig A, Osiniri I, Soriano-Rodriguez P, et al. Undercarboxylated osteocalcin relates to cardiovascular risk markers in offspring of families with metabolic syndrome. Atherosclerosis. 2014;233(1):272–277. atherosclerosis.2014.01.002
   PubMed Web of Science ®Google Scholar
• Zhang M, Ni Z, Zhou W, et al. Undercarboxylated osteocalcin as a biomarker of subclinical atherosclerosis in non-dialysis patients with chronic kidney disease. J Biomed Sci. 2015;22:75.
   PubMed Web of Science ®Google Scholar
• Tacey A, Smith C, Woessner MN, et al. Undercarboxylated osteocalcin is associated with vascular function in female older adults but does not influence vascular function in male rabbit carotid artery ex vivo. PLoS One. 2020;15(11):e0242774.
   PubMed Web of Science ®Google Scholar
• Choi BH, Joo NS, Kim MJ, et al. Coronary artery calcification is associated with high serum concentration of undercarboxylated osteocalcin in asymptomatic Korean men. Clin Endocrinol. 2015;83(3):320–326.
   PubMed Web of Science ®Google Scholar
• Smith C, Voisin S, Al Saedi A, et al. Osteocalcin and its forms across the lifespan in adult men. Bone. 2020;130:115085.
   PubMed Web of Science ®Google Scholar
• Kanazawa I, Yamaguchi T, Sugimoto T. Relationship between bone biochemical markers versus glucose/lipid metabolism and atherosclerosis; a longitudinal study in type 2 diabetes mellitus. Diabetes Res Clin Pract. 2011;92(3):393–399.
   PubMed Web of Science ®Google Scholar
• Dhore CR, Cleutjens JP, Lutgens E, et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21(12):1998–2003.
   PubMed Web of Science ®Google Scholar
• Foresta C, De Toni L, Selice R, et al. Increased osteocalcin-positive endothelial progenitor cells in hypogonadal male patients. J Endocrinol Invest. 2010;33(7):439–442.
   PubMed Web of Science ®Google Scholar